{"product_id":"cleveland-clinic-10th-annual-basic","title":"Cleveland Clinic 10th Annual Basic and Clinical Immunology for the Busy Clinician 2022","description":"\u003ch1 class=\"product_title entry-title\"\u003eCleveland Clinic 10th Annual Basic and Clinical Immunology for the Busy Clinician 2022\u003c\/h1\u003e\u003cbr\u003eCleveland Clinic\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\u003cstrong\u003e Include: 18 videos + 14 pdfs , size: 6.87 GB\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003e Target Audience: rheumatologists; dermatologists; infectious disease clinicians; allergists; clinical immunologists\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cstrong\u003e Information:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eCleveland Clinic\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cbr\u003e\u003cbr\u003ePlan to attend this one-of-a-kind symposium that provides a unique array of educational offerings in the field of clinical immunology. This symposium is designed for busy clinicians who desire to increase their declarative and procedural knowledge, as it applies to patient care.\u003cbr\u003e\u003cbr\u003eWhether you prefer to join in-person in Scottsdale, AZ, or join by live stream, you will receive instruction from leading experts in the field of immunology. Our Saturday session begins with an overview of advances in immunology, and leads into a review of hot topics in immunology 2023. Our afternoon session focuses on the standard of care for SpA and PsA, along with new developments in treatments for SAPHO, SLE, and complement and vasculitis. On Sunday, our program is devoted to topics related to COVID-19 and rheumatologists\/clinical immunologists, including vaccines, long COVID, and cytokine storm. Don’t miss our flipped classroom panel discussion. We’ll conclude the course with a discussion of wellness and treating the COVID-19 patient long-term.\u003cbr\u003e\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\n\u003cbr\u003eBy attending, participants will be able to do the following:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eExplain the integrated immune response as it applies to host defense ad immune-mediated diseases and recognize recent advances that may influence patient care.\u003c\/li\u003e\n\u003cli\u003eDescribe and critically appraise the immunologic mechanisms of action for targeted therapies and targeted synthetic therapies regarding the efficacy and safety across the immune mediate inflammatory diseases including psoriatic arthritis (PsA), spondyloarthritis (SpA), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), vasculitis, and others.\u003c\/li\u003e\n\u003cli\u003eDescribe recent advances in prevention and outpatient treatment of COVID-19 in immunocompromised patients, and the use of immune based therapies for hospitalized patients with severe disease.\u003c\/li\u003e\n\u003cli\u003eCritically appraise data on the role of wellness behaviors on general health, immunologic health, and management of COVID-19 and its complications.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWho Should Attend?\u003c\/h3\u003e\n\u003cbr\u003eThe symposium is directed to rheumatologists; dermatologists; infectious disease clinicians; allergists; clinical immunologists; specialists in integrative medicine, preventive medicine, wellness, and primary care; nurses; physicians assistants, and other health care professionals caring for patients with immunologic diseases.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAutoimmunity and COVID-19 – the new horizon.mp4\u003c\/li\u003e\n\u003cli\u003eAutoimmunity and COVID-19 – the new horizon.pdf\u003c\/li\u003e\n\u003cli\u003eBreakthrough COVID on IMIDS.mp4\u003c\/li\u003e\n\u003cli\u003eBreakthrough COVID on IMIDS.pdf\u003c\/li\u003e\n\u003cli\u003eCOVID-19 and the risks from immunomodulatory therapies.mp4\u003c\/li\u003e\n\u003cli\u003eCOVID-19 and the risks from immunomodulatory therapies.pdf\u003c\/li\u003e\n\u003cli\u003eCOVID-19 at two years- politics, science and challenges.pdf\u003c\/li\u003e\n\u003cli\u003eCOVID-19 Autoimmunity, Prevention and Management- Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eCOVID-19 Round up in Other Immune-Mediated Inflammatory Diseases- Special Considerations Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eDermatologic disorders and COVID-19.mp4\u003c\/li\u003e\n\u003cli\u003eDermatologic disorders and COVID-19.pdf\u003c\/li\u003e\n\u003cli\u003eDisease related factors and the risk of infection acquisition and disease progression.mp4\u003c\/li\u003e\n\u003cli\u003eDisease related factors and the risk of infection acquisition and disease progression.pdf\u003c\/li\u003e\n\u003cli\u003eIBD and COVID-19.mp4\u003c\/li\u003e\n\u003cli\u003eIBD and COVID-19.pdf\u003c\/li\u003e\n\u003cli\u003eIn-patient use of immunomodulatory therapies in COVID-19 anti-cytokine antibodies, targeted synthetic.mp4\u003c\/li\u003e\n\u003cli\u003eIn-patient use of immunomodulatory therapies in COVID-19 anti-cytokine antibodies, targeted synthetic.pdf\u003c\/li\u003e\n\u003cli\u003eJAK inhibitors in the COVID era – assessing risks and benefits.mp4\u003c\/li\u003e\n\u003cli\u003eJAK inhibitors in the COVID era – assessing risks and benefits.pdf\u003c\/li\u003e\n\u003cli\u003eLong COVID – what do we know and what should we do.mp4\u003c\/li\u003e\n\u003cli\u003eLong COVID – what do we know and what should we do.pdf\u003c\/li\u003e\n\u003cli\u003eManaging COVID-19 in Immune-Mediated Inflammatory Disease Patients- Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eMultiple Sclerosis and COVID-19.mp4\u003c\/li\u003e\n\u003cli\u003eMultiple Sclerosis and COVID-19.pdf\u003c\/li\u003e\n\u003cli\u003ePrinciples of outpatient management ‘when IMID patient calls with possible COVID’.pdf\u003c\/li\u003e\n\u003cli\u003ePrinciples of outpatient management when IMID patient calls with possible COVID.mp4\u003c\/li\u003e\n\u003cli\u003eRheumatic Diseases and COVID-19- Challenges for Science in February 2022.mp4\u003c\/li\u003e\n\u003cli\u003eRheumatic Diseases and COVID-19- February 2022 Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eRJ Fasenmyer Center for Clinical immunology Annual Lectureship Understanding immunity and immune memory to SARS-C.mp4\u003c\/li\u003e\n\u003cli\u003eRJ Fasenmyer Center for Clinical immunology Annual Lectureship Understanding immunity and immune memory to SARS-C.pdf\u003c\/li\u003e\n\u003cli\u003eVaccine response in IMIDS – challenges and strategies.mp4\u003c\/li\u003e\n\u003cli\u003eVaccine response in IMIDS – challenges and strategies.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\u003cbr\u003e ","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954413998178,"sku":"MED-AMB03070","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Cleveland-Clinic-10th-Annual-Basic-and-Clinical-Immunology-for-the-Busy-Clinician-2022.jpg?v=1779375914","url":"https:\/\/meducourse.com\/products\/cleveland-clinic-10th-annual-basic","provider":"Meducourse","version":"1.0","type":"link"}